Amici Capital’s Calithera Biosciences, Inc CALA Stock Holding History

Amici Capital’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-318	Closed	-$21K	–	96
2016 Q3	$21K	Hold	318	–	–	0.01%	88
2016 Q2	$24K	Hold	318	–	–	﹤0.01%	119
2016 Q1	$36K	Buy	+318	New	+$36K	﹤0.01%	110
2015 Q4	–	Sell	-318	Closed	-$35K	–	142
2015 Q3	$35K	Hold	318	–	–	﹤0.01%	144
2015 Q2	$45K	Hold	318	–	–	﹤0.01%	135
2015 Q1	$104K	Buy	+318	New	+$113K	﹤0.01%	121

Other funds holding CALA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Amici Capital's CALA Position: Q4 2016 in Review

Amici Capital sold out of Calithera Biosciences, Inc (CALA) in Q4 2016, closing a stake of 318 shares — an estimated $21K sold.

Amici Capital first reported a position in CALA in Q1 2015 and held it in 6 quarters. The position peaked at $104K in Q1 2015. 33 funds tracked by Wall St. Rank hold CALA as of Q4 2016.

Amici Capital reported no remaining Calithera Biosciences, Inc position as of Q4 2016 after selling out during the quarter.
Amici Capital sold 318 Calithera Biosciences, Inc shares in Q4 2016, an estimated $21K.
Amici Capital first reported a position in Calithera Biosciences, Inc in Q1 2015 and held it in 6 quarters.
Amici Capital's Calithera Biosciences, Inc position peaked at $104K in Q1 2015.
33 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2016.

Based on Amici Capital's 13F filing for Q4 2016, filed 14 Feb 2017.